GHRP-2 (Pralmorelin): Potent GH Release, Thin Outcome Data
GHRP-2 is a ghrelin-receptor agonist that raises growth hormone strongly and is a licensed diagnostic agent in Japan. Evidence, protocols, safety, legal status.
Peptide Therapy
Growth Hormone Peptides
5 articles on Growth Hormone Peptides by Dr. med. univ. Julian Douwes: GHRP-2 (Pralmorelin): Potent GH Release, Thin Outcome Data; and more.
01
02
GHRP-6: The Original GH-Releasing Peptide, Hunger Included
GHRP-6 is the first well-characterised ghrelin-receptor agonist. What the human pharmacology shows, the cytoprotection research, dosing and legal status.
03
Hexarelin: The Most Potent GHRP, and Why It Fades
Hexarelin releases more growth hormone than any common GHRP, binds CD36 in the heart, and blunts its own response within weeks. Evidence, dosing, safety, law.
04
Tesamorelin: Visceral Fat, Liver Fat and the Trials Behind It
Tesamorelin is the only GHRH analogue with phase 3 trials and an FDA approval. What it does to visceral and liver fat, plus dosing, safety and off-label use.
05
Tesamorelin and the Aging Brain: One Trial, Many Questions
A 2012 RCT linked the GHRH analogue tesamorelin to better executive function in older adults. Why one trial is not enough, plus safety and legal status.
06
Sermorelin vs CJC-1295: Which Growth Hormone Peptide Is Right for You?
Sermorelin and CJC-1295 both stimulate growth hormone release, but differ in half-life, pulsatility, and clinical use. A physician's comparison of both peptides.
